Relay Therapeutics (RLAY) Return on Sales (2021 - 2026)
Relay Therapeutics' (RLAY) quarterly Return on Sales came in at 0.26% in Q1 2026, down 16.0% year-on-year from 0.31% in Q1 2025, and down 426.24% on a QoQ basis from 0.05% in Q4 2025.
Relay Therapeutics (RLAY) Return on Sales (2021 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has 6 years of Return on Sales data on file, last reported at 0.26% in Q1 2026.
- On a quarterly basis, Return on Sales fell 16.0% year-over-year to 0.26% in Q1 2026; TTM through Mar 2026 was 0.25%, a 72.0% increase from a year earlier, with the FY2025 full-year figure at 0.49%, up 28.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.26%, down from 0.05% in the prior quarter.
- Over the last five years, Return on Sales for RLAY reached as high as 892.69% in Q4 2023 and fell as low as 9.45% in Q2 2023.
- Historically, Return on Sales has averaged 50.9% across 5 years, with a median of 0.75% in 2024.
- Across the five-year window, Return on Sales surged 89566 bps in 2023 and slumped 89344 bps in 2024, its largest moves.
- Year by year, Return on Sales stood at 2.97% in 2022, then soared by 30190 bps to 892.69% in 2023, then slumped by 100 bps to 0.75% in 2024, then surged by 93 bps to 0.05% in 2025, then plunged by 426 bps to 0.26% in 2026.
- Per Business Quant data, the three most recent Return on Sales figures were 0.26% in Q1 2026, 0.05% in Q4 2025, and 0.85% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Relay Therapeutics | 3.43 Bn | 3.43 Bn | - | -0.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.26% |
| Dec 31, 2025 | -0.05% |
| Sep 30, 2025 | -0.85% |
| Jun 30, 2025 | -1.09% |
| Mar 31, 2025 | -0.10% |
| Dec 31, 2024 | -0.75% |
| Sep 30, 2024 | -0.35% |
| Jun 30, 2024 | -0.10% |
| Mar 31, 2024 | -0.08% |
| Dec 31, 2023 | 892.69% |
| Sep 30, 2023 | -0.03% |
| Jun 30, 2023 | -9.45% |
| Mar 31, 2023 | -4.45% |
| Dec 31, 2022 | -2.97% |
| Sep 30, 2022 | -2.48% |
| Jun 30, 2022 | -2.53% |
| Mar 31, 2022 | -1.91% |
| Dec 31, 2021 | -1.30% |
| Sep 30, 2021 | -0.93% |
| Jun 30, 2021 | -2.30% |